The [[adverse drug reaction|adverse effects]] of vatalanib appear similar to those of other VEGF inhibitors. In the CONFIRM trials, the most common side effects were [[hypertension|high blood pressure]], gastrointestinal upset ([[diarrhea]], [[nausea]], and [[vomiting]]), [[fatigue (medical)|fatigue]], and [[dizziness]].<ref name=Los/>

 

